Extremely significant negative changes in MediWound Ltd (NASDAQ: MDWD) investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, and its shorter term price trend turned down.
Recent meaningful negative changes in fundamentals have affected MediWound Ltd (NASDAQ: MDWD): the stock’s power rating fell below 50, and significant quarterly earnings deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of F. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
MediWound has a current Value Trend Rating of F (Lowest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. MediWound has a slightly negative Power Rating of 36 and a very low Appreciation Score of 11, triggering the Lowest Value Trend Rating.
Recent Price Action
On 1/8/25, MediWound Ltd (NASDAQ: MDWD) stock suffered a large decline of -6.8%, closing at $16.01. Moreover, unusually high trading volume at 173% of normal accompanied the decline. The stock has performed in line with the market over the last nine months and has declined -10.6% during the last week.
Be the first to comment